Sort
30,917 grants matching “tumor microenvironment”
The Roles of Lymphoid Tissue Microenvironments in Guiding the Immune Response
$441,250Michael Gerner · University Of Washington · R01 · FY2022 · AI
The Roles of Lymphoid Tissue Microenvironments in Guiding the Immune Response
$441,250Michael Gerner · University Of Washington · R01 · FY2021 · AI
Enlisting HPV integration events to illuminate drivers and target treatment in invasive cervical cancer
$441,173Janet Rader · Medical College Of Wisconsin · R01 · FY2024 · CA
Regulation of tumor-infiltrating T cells by macrophages
$441,166Yiping Yang · Ohio State University · R01 · FY2021 · CA
Exosomes in tumor cell-mesenchymal stromal cell interaction
$441,121Yves A Declerck · Children'S Hospital Of Los Angeles · R01 · FY2020 · CA
Antagonistic actions of IRF4 and BACH2 in regulating Germinal Center B cell fates and promoting Lymphomagenesis
$441,098Patrizia Mondello · Mayo Clinic Rochester · R21 · FY2025 · AI
Targeting TREM2 to boost anti-cancer therapy
$441,087Marco Colonna · Washington University · R01 · FY2025 · CA
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
$441,049Bhuvaneswari Ramaswamy · Ohio State University · R01 · FY2020 · CA
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
$441,049Bhuvaneswari Ramaswamy · Ohio State University · R01 · FY2019 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
$440,978Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2015 · CA
Neoadjuvant immunotherapy approaches to early stage melanoma
$440,937Meenhard Herlyn · Wistar Institute · P50 · FY2023 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$440,875Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$440,874Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$440,797Darell D Bigner · Duke University · P01 · FY2018 · CA
Development of Chimeric Antigen Receptor Phagocytes Against Glioblastoma
$440,781Siddhartha S. Mitra · University Of Colorado Denver · R01 · FY2025 · CA
Systematic characterization of cancer variants using single-cell functional genomics
$440,728Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R33 · FY2022 · CA
Targeting immune suppressive microenvironment in ATC
$440,718James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Targeting immune suppressive microenvironment in ATC
$440,718James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Microenvironment Modulates HIV Replication in Macrophage
$440,667Philippe Andre Gallay · Scripps Research Institute, The · R01 · FY2007 · AI
Exploration of different immunotherapy modalities in osteosarcoma
$440,640Payal Agarwal · Auburn University At Auburn · R15 · FY2023 · CA
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
$440,630Bruce K Walcheck · University Of Minnesota · R01 · FY2025 · CA
The molecular mechanisms of progestin efficacy and resistance in EC-AEH
$440,602Miles A Pufall · University Of New Mexico Health Scis Ctr · P01 · FY2025 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$440,580Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2019 · CA
Multiscale anisotropy analysis of breast tissue subtypes from mammography and pathology
$440,561Andre Khalil · University Of Maine Orono · R15 · FY2025 · CA
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$440,560Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2024 · CA